YR
Yugandar Reddy Yenkekalya
About Yugandar Reddy Yenkekalya
Data last updated:
Yugandar Reddy Yenkekalya is a Director at Kaizen Oncology Private Limited (since 2023) and Director at Ninaad Healthcare Foundation (since 2023). The companies operate in Healthcare. The largest current company by reported revenue is Kaizen Oncology Private Limited at ₹16.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kaizen Oncology Private Limited U86100TS2023PTC171156 | Director | 16 Mar 2023 | 2023 | ₹16.75 Cr (FY 2025) | Active |
| Ninaad Healthcare Foundation U86909TS2023NPL176192 | Director | 18 Aug 2023 | 2023 | Active |
Board colleagues of Yugandar Reddy Yenkekalya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Koppaka | 10075954 | Kaizen Oncology Private Limited , Ninaad Healthcare Foundation | Director |
| Sathish Pawar | 03510398 | Kaizen Oncology Private Limited , Ninaad Healthcare Foundation | Director |
| Sudha Sinha | 10056502 | Kaizen Oncology Private Limited , Ninaad Healthcare Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yugandar Reddy Yenkekalya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yugandar Reddy Yenkekalya
Yugandar Reddy Yenkekalya currently holds 2 directorships: Kaizen Oncology Private Limited (Director, since 16 Mar 2023, revenue ₹16.75 Cr (FY 2025)); Ninaad Healthcare Foundation (Director, since 18 Aug 2023).
Yugandar Reddy Yenkekalya was first appointed on 16 Mar 2023 as Director at Kaizen Oncology Private Limited.
The current boards of Yugandar Reddy Yenkekalya's companies include Deepak Koppaka (Kaizen Oncology Private Limited), Sathish Pawar (Kaizen Oncology Private Limited), Sudha Sinha (Kaizen Oncology Private Limited).